Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vicarious Surgical Inc. RBOT

Healthcare  —  Medical Devices
0.10 0.05 100.00% as of 25 Sep
Market cap
$14.3M
P/E
0.0×
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vicarious Surgical Inc. (RBOT) Business Profile

Updated before January 2025

Company Overview

Vicarious Surgical Inc. (RBOT) is a cutting-edge medical technology company that specializes in the development of advanced robotic systems for minimally invasive surgery. Founded in 2014 by Adam Sachs and Sammy Khalifa, the company is headquartered in Waltham, Massachusetts. Vicarious Surgical aims to revolutionize the field of surgical robotics by combining human-like dexterity with state-of-the-art visualization technology. The company is led by CEO Adam Sachs, who brings a wealth of expertise in robotics and healthcare innovation, and a team of seasoned executives and engineers dedicated to advancing surgical care.

Core Business Segments

Robotic Surgical Systems

Vicarious Surgical’s flagship product is its next-generation robotic surgical system, which integrates proprietary virtual reality (VR) technology with advanced robotics. This system is designed to enhance precision, reduce invasiveness, and improve patient outcomes. Key features include:

  • Human-like Dexterity: The robotic arms mimic the movements of a surgeon’s hands, allowing for greater precision and control.
  • 3D Visualization: The VR interface provides surgeons with an immersive, high-definition view of the surgical site.
  • Compact Design: Unlike traditional robotic systems, Vicarious Surgical’s platform is designed to be smaller and more portable, making it accessible to a wider range of healthcare facilities.

Software and Simulation Tools

The company also offers software solutions that complement its robotic systems. These tools include:

  • Surgical Planning Software: Enables surgeons to plan procedures in advance, improving efficiency and outcomes.
  • Training Simulations: Provides a virtual environment for surgeons to practice and refine their skills using the robotic system.

Support and Maintenance Services

To ensure optimal performance of its systems, Vicarious Surgical provides comprehensive support services, including:

  • Installation and Setup: Assistance with deploying the robotic system in healthcare facilities.
  • Maintenance and Upgrades: Regular updates and servicing to keep the systems running smoothly.
  • Training Programs: Hands-on training for surgeons and operating room staff.

Business Model

Vicarious Surgical operates on a hybrid business model that combines product sales with recurring revenue streams from services and software. The company generates revenue through:

  • System Sales: One-time sales of its robotic surgical systems to hospitals and surgical centers.
  • Software Licensing: Subscription-based licensing for its surgical planning and simulation tools.
  • Service Contracts: Long-term contracts for maintenance, training, and support services.

This diversified revenue model ensures a steady income stream while fostering long-term relationships with healthcare providers.

Strategic Direction

Vicarious Surgical is focused on expanding its market presence and driving innovation in surgical robotics. Key strategic initiatives include:

  • Product Development: The company is investing heavily in R&D to enhance the capabilities of its robotic systems and develop new features.
  • Global Expansion: Plans to enter new markets, particularly in Europe and Asia, to tap into the growing demand for advanced surgical technologies.
  • Sustainability Goals: Vicarious Surgical is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and minimizing waste.
  • Partnerships and Collaborations: The company is exploring partnerships with healthcare providers, academic institutions, and technology firms to accelerate innovation and adoption.

Competitive Landscape

Vicarious Surgical operates in a highly competitive market, facing competition from established players and emerging startups. Key competitors include:

  • Intuitive Surgical: The market leader in robotic-assisted surgery, known for its da Vinci Surgical System.
  • Medtronic: A global medical technology company with a strong presence in surgical robotics.
  • Johnson & Johnson (Ethicon): Offers a range of surgical solutions, including robotic systems.
  • CMR Surgical: A UK-based company specializing in robotic-assisted surgery.

Despite the competition, Vicarious Surgical differentiates itself through its innovative technology, compact design, and focus on accessibility.

Risk Factors

Like any business, Vicarious Surgical faces several risks that could impact its operations and growth:

  • Regulatory Challenges: The company must navigate complex regulatory requirements to bring its products to market.
  • Market Dependence: Reliance on the adoption of robotic systems by healthcare providers could pose a risk if demand slows.
  • Supply Chain Disruptions: Dependence on specialized components makes the company vulnerable to supply chain issues.
  • Competition: Intense competition from established players could limit market share and pricing power.
  • Technological Risks: Rapid advancements in technology could render the company’s products obsolete if it fails to innovate.

Recent Developments

Vicarious Surgical has made significant strides in recent years, including:

  • FDA Clearance: The company received FDA clearance for its robotic system, paving the way for commercialization in the U.S.
  • Funding Rounds: Secured substantial funding from investors to support R&D and market expansion.
  • Partnerships: Collaborated with leading healthcare institutions to validate the efficacy of its technology.
  • Product Enhancements: Introduced new features to its robotic system, such as improved haptic feedback and enhanced visualization capabilities.

Investment Considerations

Strengths

  • Innovative Technology: Vicarious Surgical’s robotic systems offer unique features that set them apart from competitors.
  • Growing Market: The global market for surgical robotics is expected to grow significantly, providing ample opportunities for expansion.
  • Strong Leadership: The company is led by a team of experienced professionals with a proven track record in healthcare and technology.

Risks

  • High Competition: The presence of established players could limit market penetration.
  • Regulatory Hurdles: Delays in regulatory approvals could impact commercialization timelines.
  • Financial Risks: As a relatively young company, Vicarious Surgical may face challenges in achieving profitability.

Conclusion

Vicarious Surgical Inc. is well-positioned to disrupt the surgical robotics market with its innovative technology and strategic vision. While the company faces challenges such as competition and regulatory hurdles, its focus on innovation and accessibility gives it a strong foundation for future growth. As the demand for minimally invasive surgical solutions continues to rise, Vicarious Surgical is poised to play a pivotal role in shaping the future of healthcare.